BioAtla Inc. (BCAB)
0.27
-0.03 (-11.45%)
At close: Mar 04, 2025, 11:18 AM
BioAtla Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -123.46M | -106.48M | -95.4M | -35.85M | -29.86M | -28.98M |
| Depreciation & Amortization | 1.22M | 1.2M | 1.33M | 1.01M | 860K | 794K |
| Stock-Based Compensation | 13.54M | 14.56M | 25.12M | 3.02M | -6.4K | 2.64K |
| Other Working Capital | -604K | 287K | -568K | -838K | 21.97M | -10.15M |
| Other Non-Cash Items | 2K | 13K | 3K | -6.48M | -5.75M | 2.57M |
| Deferred Income Tax | n/a | n/a | -686K | 4.46M | 6.4K | n/a |
| Change in Working Capital | 4.68M | 287K | 7.42M | -2.5M | 25.1M | -9.7M |
| Operating Cash Flow | -104.02M | -90.42M | -62.21M | -36.33M | -9.64M | -35.32M |
| Capital Expenditures | -98K | -268K | -924K | -590K | -1.51M | -988K |
| Acquisitions | n/a | 3K | n/a | -19K | -5K | 19K |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 3.00 | -924K | 19K | 5K | n/a |
| Investing Cash Flow | -98K | -265K | -924K | -590K | -1.51M | -988K |
| Debt Repayment | n/a | n/a | n/a | 3.43M | 4M | 5M |
| Common Stock Repurchased | -259 | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 77K | -469K | -1.48M | 68.16M | -5K | 19K |
| Financial Cash Flow | 77K | 61.21K | 69.51M | 271.82M | 4M | 5.02M |
| Net Cash Flow | -104.04M | -29.47M | 6.37M | 234.9M | -7.16M | -31.29M |
| Free Cash Flow | -104.11M | -90.69M | -63.14M | -36.92M | -11.15M | -36.3M |